Skip Navigation
Skip Website Tools

Contact Info

Beth Spinelli  
Project Officer, Drug Development Section
Office of Biodefense Research Affairs
spinellb@niaid.nih.gov

Microbiology and Infectious Diseases Resources

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Interventional Agent Development Services

About

What services does this resource provide?

The Interventional Agent Development Services program provides services to facilitate preclinical development of therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins, such as imaging and skin test reagents. Note: Devices are excluded.

Services include

  • Lead identification and development
  • Chemistry and manufacturing
  • In vitro and in vivo preclinical safety, toxicology, and biokinetics
  • Preclinical development, planning, and evaluation

See examples of services within each of these categories.

A suite of services is provided to support the development of products directed against the full range of pathogens, including bacteria, viruses, parasites, fungi, and other agents such as toxins and prion proteins.

Services will be conducted at the appropriate regulatory compliance level dependent on the stage of product development.

Note: Resources are limited and intended to fill critical gaps and are not to be the sole source of product development. Preliminary data to support program participation are required.

Access

Last Updated March 05, 2014